Severe chronic kidney disease is associated with poor survival after initial CRT ‐defibrillator tachyarrhythmia therapy
ConclusionsSurvival after appropriate tachyarrhythmia therapies, particularly shocks, is attenuated in patients with GFR ≤30. This raises concern over potential lack of survival benefit conferred by CRT‐defibrillators versus CRT‐pacemakers in this population.This article is protected by copyright. All rights reserved
Source: Pacing and Clinical Electrophysiology : PACE - Category: Cardiology Authors: Evan C. Adelstein,
Samir Saba,
Sandeep Jain,
Norman C. Wang Tags: DEVICES Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Chronic Kidney Disease | Diabetes | Endocrinology | Heart | Heart Disease | Urology & Nephrology